Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04721158 · ClinicalTrials.gov registry record · NA
CGM Use in Children With Type 2 Diabetes
A NA study, sponsored by Johns Hopkins University.
- Completed
- Registry status
- NA
- Development phase
- 41
- Enrollment target
NCT04721158: Completed NA study, sponsored by Johns Hopkins University.
NCT04721158 is a NA study that has completed, run by Johns Hopkins University. The registered enrollment target is 41 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04721158, a NA study, has completed, sponsored by Johns Hopkins University.
- COMPLETED
- Registry status
- NA
- Development phase
- 41 participants
- Enrollment target
Study Summary
The purpose of this prospective study is to determine if trial use of a Dexcom G6 CGM system for a 10 day wear period in pediatric Type 2 diabetes patients improves short term time in range glucose control and 3-6 month glycemic control.
Interventions
- DEVICE Continuous glucose monitor
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 41 participants |
| Start Date | 2021-01-17 |
| Est. Completion | 2022-07-28 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04721158
The ClinicalTrials.gov registry entry for NCT04721158 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 41 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Johns Hopkins University, which has 1,448 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Continuous glucose monitor is the first listed.
NCT04721158 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04721158 about?
NCT04721158 is a clinical study titled "CGM Use in Children With Type 2 Diabetes". The purpose of this prospective study is to determine if trial use of a Dexcom G6 CGM system for a 10 day wear period in pediatric Type 2 diabetes patients improves short term time in range glucose control and 3-6 month glycemic control.
What is the current status of trial NCT04721158?
This trial is currently completed. It is a NA study. The enrollment target is 41 participants. The study started on 2021-01-17. Estimated completion is 2022-07-28.
What interventions are being tested in trial NCT04721158?
The interventions under investigation include: Continuous glucose monitor (DEVICE).
Who is sponsoring clinical trial NCT04721158?
This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.